If you have been wondering whether Exact Sciences is still worth buying after its huge run, you are not alone. This breakdown is designed to help you decide if the current price makes sense. The stock ...

Abbott made a takeover offer for Exact Sciences. The two companies want to team up to combat cancer. Under the terms of the deal, Exact Sciences' stockholders would receive $105 per share in cash. The ...

Abbott to buy Exact Sciences in $23 billion deal Exact's flagship colorectal cancer test to join Abbott's portfolio Abbott eyes international expansion for Exact's tests Aims for broad reimbursement ...

Abbott Laboratories ABT0.97%increase; green up pointing triangle agreed to acquire cancer diagnostics company Exact Sciences EXAS-0.03%decrease; red down pointing triangle in a deal valued at about ...

(RTTNews) - Abbott Laboratories (ABT) on Thursday said it has agreed to acquire Exact Sciences (EXAS) in a transaction worth an enterprise value of about $23 billion. Under the terms of the agreement, ...

(Reuters) -Abbott will buy cancer test maker Exact Sciences in a deal valued at up to $23 billion, including debt, marking one of its largest purchases in nearly a decade and a bold entry into the ...

Abbott announced Thursday morning that it is acquiring Exact Sciences for $21 billion. The deal values Exact Sciences at $105 per share, representing a 22% premium to the cancer screening company’s ...

Abbott's acquisition of Exact Sciences aims to improve cancer diagnostics and expand access to early detection and management. Exact Sciences' products, including Cologuard and Oncotype DX, will ...

Nov 19 (Reuters) - Medical device maker Abbott Laboratories (ABT.N), opens new tab is nearing a potential takeover of cancer test maker Exact Sciences Corp (EXAS.O), opens new tab, Bloomberg News ...

HICL Infrastructure PLC and Renewables Infrastructure Group, known as TRIG, agreed to merge in a deal that creates a company with net assets of over 5.3 billion pounds ($6.98 billion). The companies ...

TRIG had been trading on a 34% discount to net asset value before the news and Mould said its investors “should be happy they’re being offered a partial cash exit at a 10% discount to 30 September’s ...

If you're reading this, you've probably found yourself staring at Exact Sciences stock on your watchlist, asking the million-dollar question: is now the time to act? After a rollercoaster year, the ...